سعر سوبر فيغا 50 مجم 2026

Sildenafil 50 mg oral tablets, pack of 4 tablets (per the source sheet).

• Treatment of erectile dysfunction.Population: Adult menDailyMed (U.S. National Library of Medicine)

• Most common (>=2%): headache, flushing, dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness and rash.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Use with nitric oxide donors such as organic nitrates or nitrites in any form (potentiated hypotension).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Known hypersensitivity to sildenafil or any tablet component.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant use of guanylate cyclase stimulators such as riociguat.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Not for men in whom sexual activity is inadvisable because of cardiovascular status.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Seek emergency treatment for erections lasting more than 4 hours; use with caution in conditions predisposing to priapism.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Stop and seek medical attention for sudden loss of vision (possible NAION) or sudden decrease or loss of hearing.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Organic nitrates / nitric oxide donorsContraindicated: sildenafil potentiates their hypotensive effect.DailyMed (U.S. National Library of Medicine)
• RitonavirSildenafil levels increased about 11-fold; recommended dose 25 mg with a maximum of 25 mg in 48 hours.DailyMed (U.S. National Library of Medicine)
• Strong CYP3A4 inhibitors (ketoconazole, itraconazole, saquinavir) or erythromycinConsider a starting dose of 25 mg.DailyMed (U.S. National Library of Medicine)

• Not indicated for use in females; no human pregnancy data; no adverse developmental outcomes in rat and rabbit studies.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Not indicated for use in females; limited data show sildenafil and its active metabolite are present in human milk.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Sildenafil: Inhibits PDE5, which degrades cGMP in the corpus cavernosum, enhancing the nitric oxide effect during sexual stimulation.